Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma

被引:1
|
作者
Xiong, Guohai [1 ,2 ]
Shan, Jinmei [1 ,2 ]
Chong, Qingguo [1 ,2 ]
Cui, Yueqing [1 ,2 ]
机构
[1] Yancheng Third Peoples Hosp, Dept Gynaecol, Yancheng 224008, Peoples R China
[2] Nanjing Med Univ, Dept Gynaecol, Yancheng Sch Clin Med, Yancheng 224008, Peoples R China
来源
AGING-US | 2024年 / 16卷 / 08期
关键词
tertiary lymphoid structures; anti-tumor immunity; cervical cancer; prognosis; B-CELLS; IMMUNOTHERAPY; LANDSCAPE; REVEAL;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Cervical squamous carcinoma (CESC) is the main subtype of cervical cancer. Unfortunately, there are presently no effective treatment options for advanced and recurrent CESC. Tertiary lymphoid structures (TLSs) are clusters of lymphoid cells that resemble secondary lymphoid organs; nevertheless, there is no summary of the clinical importance of TLS in CESC. Methods: A large set of transcriptomic and single-cell RNA-sequencing (scRNA-seq) datasets were used to analyze the pattern of TLS and its immuno-correlations in CESC. Additionally, an independent in-house cohort was collected to validate the correlation between TLS and TME features. Results: In the current study, we found that the presence of TLS could predict better prognosis in CESC and was correlated with the activation of immunological signaling pathways and enrichment of immune cell subpopulations. In addition, TLS was associated with reduced proliferation activity in tumor cells, indicating the negative correlation between TLS and the degree of malignancy. Last but not least, in two independent immunotherapy cohorts, tumors with the presence of TLS were more sensitive to immunotherapy. Conclusion: Overall, TLS is related to an inflamed TME and identified immune-hot tumors, which could be an indicator for the identification of immunological features in CESC.
引用
收藏
页码:6898 / 6920
页数:23
相关论文
共 50 条
  • [41] Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer
    Qin, Meng
    Hamanishi, Junzo
    Ukita, Masayo
    Yamanoi, Koji
    Takamatsu, Shiro
    Abiko, Kaoru
    Murakami, Ryusuke
    Miyamoto, Taito
    Suzuki, Haruka
    Ueda, Akihiko
    Hosoe, Yuko
    Horie, Akihito
    Yamaguchi, Ken
    Mandai, Masaki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1431 - 1442
  • [42] Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer
    Meng Qin
    Junzo Hamanishi
    Masayo Ukita
    Koji Yamanoi
    Shiro Takamatsu
    Kaoru Abiko
    Ryusuke Murakami
    Taito Miyamoto
    Haruka Suzuki
    Akihiko Ueda
    Yuko Hosoe
    Akihito Horie
    Ken Yamaguchi
    Masaki Mandai
    Cancer Immunology, Immunotherapy, 2022, 71 : 1431 - 1442
  • [43] Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers
    Pimenta, Erica
    Barnes, Betsy
    CANCERS, 2014, 6 (02): : 969 - 997
  • [44] HLA-A+ tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma
    Zhang, Dandan
    Jiang, Dongxian
    Jiang, Liping
    Ma, Jiakang
    Wang, Xiaobing
    Xu, Xingyu
    Chen, Ziqiang
    Jiang, Mengping
    Ye, Wenjing
    Wang, Jie
    Meng, Weida
    Qiu, Wenqing
    Hou, Yingyong
    Huang, Jing
    Jiao, Yuchen
    Liu, Yun
    Liu, Zhihua
    BRITISH JOURNAL OF CANCER, 2024, 131 (01) : 184 - 195
  • [45] TERTIARY LYMPHOID STRUCTURES AS MARKERS OF ANTI-TUMOR IMMUNITY WITH INDEPENDENT PROGNOSTIC VALUE IN THE PORTEC-3 TRIAL OF HIGH-RISK ENDOMETRIAL CANCER
    Horeweg, N.
    Workel, H.
    Loiero, D.
    Church, D.
    Vermij, L.
    Leon-Castillo, A.
    De Boer, S.
    Nout, R.
    Powell, M.
    Mileshkin, L.
    Mackay, H.
    Leary, A.
    Singh, N.
    Jurgenliemk-Schulz, I.
    Creutzberg, C. L.
    Kolzer, V.
    Nijman, H. W.
    Bosse, T.
    De Bruyn, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A99 - A101
  • [46] Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy
    Rodriguez, Anthony B.
    Engelhard, Victor H.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (11) : 1338 - 1345
  • [47] Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing cells in renal cell cancer
    Meylan, Maxime
    Petitprez, Florent
    Becht, Etienne
    Bougouein, Antoine
    Pupier, Guilhem
    Calvez, Anne
    Giglioli, Ilenia
    Verkarre, Virginie
    Lacroix, Guillaume
    Verneau, Johanna
    Sun, Chen-Ming
    Laurent-Puig, Pierre
    Vano, Yann-Alexandre
    Elaidi, Reza
    Mejean, Arnaud
    Sanchez-Salas, Rafael
    Barret, Eric
    Cathelineau, Xavier
    Oudard, Stephane
    Reynaud, Claude-Agnes
    de Reynies, Aurelien
    Sautes-Fridman, Catherine
    Fridman, Wolf Herman
    IMMUNITY, 2022, 55 (03) : 527 - +
  • [48] Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma
    Chen, Xinmian
    Chen, De-Run
    Liu, Hongmei
    Yang, Lei
    Zhang, Yutao
    Bu, Lin-Lin
    Sun, Zhi-Jun
    Cai, Lulu
    JOURNAL OF CONTROLLED RELEASE, 2022, 351 : 381 - 393
  • [49] Nanoparticle Enhanced Radiotherapy to Trigger Pyrolysis and Anti-Tumor Immunity
    Xie, C.
    Yin, H.
    Liang, D.
    Feng, Z.
    Jin, X.
    Wang, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E236 - E236
  • [50] Architecture of head and neck squamous cell carcinoma tumor microenvironment revealed: can tertiary lymphoid structures recurrence?
    Sosa, Jennifer
    Glathar, Alexandra
    Sinha, Satrajit
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (02) : 484 - 489